Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Q1 earnings season look ahead: behold the almighty dollar

As the next US earnings season draws near, concerns are beginning to surface about the impact of the strong US dollar. With a number of big Dow Jones constituents drawing a significant percentage of their revenue from overseas, investors should be more than a little worried.

US dollar
Source: Bloomberg

The year 2017 has dawned with the US dollar index at its highest level since 2002. Expectations of higher US growth, and ongoing monetary policy differentials (ie the US Federal Reserve raising rates while almost all other major central banks loosen policy) have boosted the US dollar over the past 12 months, continuing a trend that began back in 2013.

Currency movements can have a significant bearing on company earnings, a lesson that investors relearnt in 2016. The post-Brexit depreciation in sterling prompted a remarkable rally for the FTSE 100, as investors rushed to buy shares in UK companies with large overseas earnings. The lower pound would result in favourable currency translation, boosting performance. The reverse may now begin to apply for US firms. In addition, US exports will become less competitive, hitting those firms with significant activity in overseas markets.

There are a few US firms that will not feel some effect from the stronger dollar, but we can narrow down the list to some more obvious suspects. Some of these are also significant weights in the Dow, so the impact of any miss on earnings will be amplified in the broader market. The table below provides some firms that will be worth watching (sorted by Dow weighting):

Name

Revenues ex-US (%)

Dow weighting (%)

Earnings date

Goldman Sachs

43%

8.3%

18/01/17

3M Co

60%

6.2%

24/01/17

IBM Corp

50%+

5.7%

17/01/17

Boeing Co

59%

5.3%

25/01/17

Apple Inc

62%

4%

24/01/17

Exxon Mobil Corp

70%

3.1%

31/01/17

Visa Inc

48%

2.7%

2/02/17

 

A good quarterly performance will not be entirely wiped out by the rally in the dollar, but with the Federal Reserve expected to raise rates at least twice this year (with the Federal Open Market Committee itself expecting three increases), it is at present unlikely the dollar will weaken significantly. John Connally, Nixon’s Treasury Secretary, once proclaimed the dollar was ‘[the US’] currency, but [the world’s] problem’. In 2017, a strong dollar may well be a major headache for United States Inc. 

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer